Associate Professor, Obstetrics and Gynecology, Yale University School of Medicine
Obstetrics & Gynecology
Dr. Masoud Azodi, MD
|
|
Give Review
Masoud Azodi practices Obstetrics & Gynecology. He went to medical school at Wright State University Boonshoft School of Medicine. He received awards:"America's Top Doctors", "Top Doctors: New York Metro Area", "New York Magazine: Top Doctors", "CMS Meaningful Use Stage 1 Certification", "America's Top Doctors for Cancer" and "Fellow (FACOG)". Masoud Azodi is a published doctor and has 68 publications published. The lastest was: 'Twenty-four-hour heart preservation using continuous cold perfusion and copper (II) complexes.' Masoud Azodi accepts Medicare.
Publications
- Dual HER2/PIK3CA Targeting Overcomes Single-Agent Acquired Resistance in HER2-Amplified Uterine Serous Carcinoma Cell Lines In Vitro and In Vivo.
- Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo.
- Weekly ixabepilone with or without biweekly bevacizumab in the treatment of recurrent or persistent uterine and ovarian/primary peritoneal/fallopian tube Cancers: A re...
- A Technique for Vascular Control During Robotic-assisted Laparoscopic Myomectomy.
- Phase 1b study of the mammalian target of rapamycin inhibitor sirolimus in combination with nanoparticle albumin-bound paclitaxel in patients with advanced solid tumors.
- Dacomitinib (PF-00299804), a second-generation irreversible pan-erbB receptor tyrosine kinase inhibitor, demonstrates remarkable activity against HER2-amplified uterin...
- Incidental Ureteral Injury and Repair during Robotic-assisted Total Laparoscopic Hysterectomy.
- Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian Cancer cell lines in vi...
- Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial Cancer in vitro and in vivo.
- T-DM1, a novel antibody-drug conjugate, is highly effective against primary HER2 overexpressing uterine serous Carcinoma in vitro and in vivo.
- An unexpected mass of the urachus: A Case Report.
- Flutamide and biomarkers of risk for ovarian Cancer: pre-clinical and clinical study.
- Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian Cancer patients treated with neoadj...
- Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian Cancer: implications for ovarian Cancer im...
- Tubulin-?-III overexpression by uterine serous Carcinomas is a marker for poor overall survival after platinum/taxane chemotherapy and sensitivity to epothilones.
- Vaginal cuff dehiscence in robotic-assisted total hysterectomy.
- Robotic-assisted laparoscopic hysterectomy: outcomes in obese and morbidly obese patients.
- Landscape of somatic single-nucleotide and copy-number mutations in uterine serous Carcinoma.
- Neoadjuvant chemotherapy (NACT) is an effective way of managing elderly women with advanced stage ovarian Cancer (FIGO Stage IIIC and IV).
- Needleless laparoscopic abdominal cerclage placement.
- Robotic versus abdominal hysterectomy for very large uteri.
- MyD88 predicts chemoresistance to paclitaxel in epithelial ovarian Cancer.
- Cervical carcinosarcoma: a case report.
- Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian Cancer.
- Induction of Human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in Human lymphocyte antigen-A2.1-positive healt...
- Enhanced ovarian Cancer tumorigenesis and metastasis by the macrophage colony-stimulating factor.
- Peritoneal tuberculosis with elevated serum Ca-125 level mimicking advanced stage ovarian Cancer: a case report.
- Human papillomavirus type 16 (HPV-16) virus-like particle L1-specific CD8+ cytotoxic T lymphocytes (CTLs) are equally effective as E7-specific CD8+ CTLs in killing aut...
- Ovarian preservation and staging in reproductive-age endometrial Cancer patients.
- Glyceraldehyde-3-phosphate dehydrogenase binds to the AU-Rich 3'' untranslated region of colony-stimulating factor-1 (CSF-1) messenger RNA in human ovarian Cancer cell...
- Weekly topotecan in heavily pretreated patients with recurrent epithelial ovarian Carcinoma.
- Improved survival in surgical stage I patients with uterine papillary serous Carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy.
- Adenoid cystic Carcinoma of the cervix.
- Atypical presentations of carboplatin hypersensitivity reactions: characterization and management in patients with gynecologic malignancies.
- Neoadjuvant chemotherapy lessens surgical morbidity in advanced ovarian Cancer and leads to improved survival in stage IV disease.
- Overexpression of EpCAM in uterine serous papillary Carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).
- Pleomorphic rhabdomyosarcoma of the Uterine corpus: a clinicopathologic study of 4 cases and a review of the literature.
- HER-2/NEU overexpression in vulvar Paget disease: the Yale experience.
- High-grade, chemotherapy-resistant ovarian Carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a ful...
- Inhibition of the c-fms proto-oncogene autocrine loop and tumor phenotype in glucocorticoid stimulated human breast Carcinoma cells.
- Primary cervical Carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclo...
- Phase II Evaluation of Phenoxodiol in Combination With Cisplatin or Paclitaxel in Women With Platinum/Taxane-Refractory/Resistant Epithelial Ovarian, Fallopian Tube, o...
- Common alleles at 6q25.1 and 1p11.2 are associated with breast Cancer risk for BRCA1 and BRCA2 mutation carriers.
- Eradication of chemotherapy-resistant CD44+ human ovarian Cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
- Expression of tissue factor in adenoCarcinoma and squamous cell Carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimer...
- Tissue factor expression in ovarian Cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
- Cervical Carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 ...
- Large prospective study of ovarian cancer screening in high-risk women: CA125 cut-point defined by menopausal Status.
- The significance of perineural invasion in early-stage Cervical cancer.
- A survey of gynecologic oncologists regarding the End-of-Life discussion: A pilot study.
- Comparison between 155 cases of robotic vs. 150 cases of open surgical staging for endometrial Cancer.
- Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a Humanized anti-Trop-2 antibody.
- Brain metastases in epithelial ovarian and primary peritoneal Carcinoma.
- Overexpression of epithelial cell adhesion molecule in primary, metastatic, and recurrent/chemotherapy-resistant epithelial ovarian Cancer: implications for epithelial...
- In vitro activity of pertuzumab in combination with trastuzumab in uterine serous papillary adenoCarcinoma.
- Her2/neu extracellular domain shedding in uterine serous Carcinoma: implications for immunotherapy with trastuzumab.
- hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary Carcinoma.
- Carcinosarcoma of the ovary.
- Serum amyloid A (SAA): a novel biomarker for uterine serous papillary Cancer.
- Maintenance of left ventricular function (90%) after twenty-four-hour heart preservation with deferoxamine.
- Twenty-four-hour heart preservation using continuous cold perfusion and copper (II) complexes.
- Serous adenoCarcinoma of the uterus presenting as paraneoplastic cerebellar degeneration.
- The effects of mannitol, albumin, and cardioplegia enhancers on 24-h rat heart preservation.
- AdenoCarcinoma in situ of the cervix: management and outcome.
- Primary fallopian tube Carcinoma with isolated torsion of involved tube.
- Patients with uterine papillary serous Cancers may benefit from adjuvant platinum-based chemoradiation.
- Extrarenal Wilms'' tumor of the Uterine corpus.
Schools
Wright State University Main Campus
Aultman Hospital
Yale University
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colpopexy
- Colpopexy With Robotic Assistance
- Colporrhaphy
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Atrophic Vaginitis
- Carcinoma in Situ
- Cervical Cancer
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors: New York Metro Area
- New York Magazine: Top Doctors
- CMS Meaningful Use Stage 1 Certification
- America's Top Doctors for Cancer
- Fellow (FACOG)
Education
-
Wright State University Boonshoft School of Medicine
Hospital
-
Yale-New Haven Hospital
Drug Facts
| NPI NUMBER | 1386632206 | |
| NPPES Provider LastName | AZODI | |
| NPPES Provider FirstName | MASOUD | |
| NPPES Provider ZIPCode | 065191369 | |
| NPPES Provider State | CT | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 341.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1386632206 |
| Last Name Of The Provider | AZODI |
| First Name Of The Provider | MASOUD |
| View All |
Similar Doctors
|
|
Dr. Dan Arin Silasi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joan A. Alvarez, MD |
|
|
Dr. Steven M. Soberman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward M. Luchansky, MD
This Doctor is OpenDoctor Recommended.
|